Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVS | LLY | JNJ | NVO | MRK |
| Company | Novartis Ag ADR | Eli Lilly and Company | Johnson & Johnson | Novo Nordisk A/S ADR | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 93.20 | 749.16 | 146.15 | 123.48 | 125.65 |
| High | 94.50 | 750.01 | 148.13 | 124.54 | 126.12 |
| Low | 93.15 | 722.07 | 144.54 | 122.46 | 124.89 |
| Last | 94.36 | 726.31 | 147.91 | 122.71 | 125.78 |
| Change | +1.79 | -19.64 | +2.17 | -0.04 | +0.55 |
| % Change | +1.93% | -2.63% | +1.49% | -0.03% | +0.44% |
| Volume | 2,338,263 | 3,486,435 | 9,583,824 | 4,984,802 | 8,385,425 |
| 20-Day Average Volume | 1,728,403 | 2,377,197 | 7,651,541 | 3,511,735 | 7,227,306 |
| Previous Close | 92.57 | 745.95 | 145.74 | 122.75 | 125.23 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.92 | 762.79 | 151.89 | 125.95 | 127.24 |
| 20-Day Raw Stochastic | 34.33% | 5.92% | 29.86% | 10.87% | 25.91% |
| 20-Day Relative Strength | 42.21% | 41.96% | 36.54% | 45.89% | 51.04% |
| Weighted Alpha | -7.80 | +79.10 | -10.81 | +46.15 | +13.88 |
| Today's Opinion | 88% Sell | 56% Buy | 88% Sell | 40% Buy | 72% Buy |
| Previous Opinion | 88% Sell | 56% Buy | 88% Sell | 56% Buy | 72% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 24% Sell | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.90% since 04/12/24 | -3.37% since 04/12/24 | +0.26% since 04/12/24 | -1.45% since 04/12/24 | +0.03% since 04/12/24 |
| Low | 92.35 on 04/18/24 | 722.07 on 04/19/24 | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 124.50 on 04/18/24 |
| High | 94.96 on 04/15/24 | 771.83 on 04/17/24 | 149.49 on 04/15/24 | 126.05 on 04/15/24 | 127.82 on 04/15/24 |
| 1-Month | |||||
| %Chg | -2.03% since 03/19/24 | -6.01% since 03/19/24 | -5.31% since 03/19/24 | -6.59% since 03/19/24 | +2.93% since 03/19/24 |
| Low | 92.35 on 04/18/24 | 722.07 on 04/19/24 | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 120.38 on 03/20/24 |
| High | 98.21 on 04/04/24 | 793.67 on 03/28/24 | 159.14 on 03/28/24 | 131.43 on 03/20/24 | 133.10 on 03/27/24 |
| 3-Month | |||||
| %Chg | -12.82% since 01/19/24 | +15.55% since 01/19/24 | -8.52% since 01/19/24 | +14.73% since 01/19/24 | +5.80% since 01/19/24 |
| Low | 92.35 on 04/18/24 | 614.82 on 01/23/24 | 143.13 on 04/18/24 | 103.38 on 01/23/24 | 117.27 on 01/23/24 |
| High | 108.78 on 01/22/24 | 800.78 on 03/04/24 | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 |
| 6-Month | |||||
| %Chg | -0.30% since 10/19/23 | +22.94% since 10/19/23 | -2.90% since 10/19/23 | +25.65% since 10/19/23 | +25.24% since 10/19/23 |
| Low | 92.19 on 10/27/23 | 547.61 on 10/31/23 | 143.13 on 04/18/24 | 92.94 on 10/27/23 | 99.80 on 11/29/23 |
| High | 108.78 on 01/22/24 | 800.78 on 03/04/24 | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 196,211,376 | 708,774,912 | 351,201,792 | 550,844,608 | 317,211,136 |
| Shares Outstanding, K | 2,119,600 | 950,164 | 2,409,783 | 4,487,532 | 2,533,028 |
| Annual Sales | 46,660,000,000 | 34,124,100,000 | 85,159,000,000 | 33,724,300,000 | 60,115,000,000 |
| Annual Net Income | 14,850,000,000 | 5,240,400,000 | 35,153,000,000 | 12,150,770,000 | 365,000,000 |
| Last Quarter Sales | 7,424,000,000 | 9,353,400,000 | 13,532,000,000 | 9,526,160,000 | 14,631,000,000 |
| Last Quarter Net Income | 8,480,000,000 | 2,189,700,000 | 4,049,000,000 | 3,175,360,000 | -1,226,000,000 |
| 60-Month Beta | 0.54 | 0.34 | 0.53 | 0.41 | 0.38 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.53 on 01/31/24 | 2.49 on 02/06/24 | 2.71 on 04/16/24 | 0.71 on 01/31/24 | 0.03 on 02/01/24 |
| Latest Earnings Date | 04/23/24 | 04/30/24 | 04/16/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | 2.431 on 03/07/24 | 1.300 on 02/14/24 | 1.190 on 02/16/24 | 0.663 on 03/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 03/07/24 | 02/14/24 | 05/20/24 | 03/22/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 13.67 | 118.79 | 13.84 | 46.04 | 83.58 |